Immunotherapy with cure potential of multi-drug resistant hematologic malignancies using IL-2 preactivated intentionally mismatched donor lymphocyte

PURPOSE: Unfortunately, cure of multi-drug resistant (MDR) hematologic malignancies remains an unmet need. Donor lymphocyte infusion (DLI) following allogeneic stem cell transplantation (SCT) can sometimes eliminate multi-drug resistant leukemia but at a risk of acute and chronic graft-vs-host disea...

Descripción completa

Detalles Bibliográficos
Autor principal: Slavin, Shimon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374770/
https://www.ncbi.nlm.nih.gov/pubmed/37202579
http://dx.doi.org/10.1007/s00432-023-04780-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374770/
https://www.ncbi.nlm.nih.gov/pubmed/37202579
http://dx.doi.org/10.1007/s00432-023-04780-5

Ejemplares similares